📞Call us
+91 80629 16290
Avience Biomedicals Ltd IPO
Status: Current
Overview
IPO date
18 Jun 2026 to 22 Jun 2026
Face value
₹ 0 per share
Price
₹ 196 to ₹208 per share
Issue Size
1,453,800 shares
(aggregating up to ₹ 30.24 Cr)
(aggregating up to ₹ 30.24 Cr)
Allotment Date
23 Jun 2026
Listing at
NSE
Issue type
Book Building - SME
Sector
Healthcare
Unlock Stock of the Month
T&C*
Strengths vs Risks of Avience Biomedicals Ltd
Know the pros & cons
Strengths
- Experienced Management Team and trained Employees.
- Optimal Utilization of Resources.
- Quality assurance and control.
- Cordial relationships with our clients.
Risks
- The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose its to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.
- The company is dependent on certain customers for a portion of its revenues. The loss of any of its major customers dues to any adverse development or significant reduction in business from its major customers may adversely affect the company business, financial condition, results of operations and future prospects.
- The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also faces risks in sourcing raw materials and components from third parties for the manufacturing and assembly of its medical equipment. Any disruption in the supply of these goods or materials could adversely impact the company business, operations, and financial condition.
- The company Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors of its Company as required under the provisions of ICDR.
- The company business derives a significant portion of its revenue from the trading sector, and any potential instability in this area could pose a risk to the company overall performance.
- The purchase and sale of medical devices and equipment for the company trading activities is significantly dependent on related parties.
- Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negatively impact the company business, financial condition, and operational results.
- The company requires sizeable amounts of working capital for its continued operation and growth. The company inability to meet its working capital requirements could has a material adverse effect on the company business, results of operations and financial condition.
- The company business depends on the efficient functioning of its manufacturing facilities and assembly units. Although the company has not received any product-related complaints, occasional machinery breakdowns in the past highlight the importance of regular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair could has an adverse impact on the company operations, cash flows, financial condition, and results.
- The company import a portion of its raw material supply from China. Restrictions on or import duties relating to materials and equipment imported for the company manufacturing operations as well as restrictions on or import duties levied on its products in the company export markets may adversely affect its business prospects, financial performance and cash flows.
- Quality problems and product liability claims could lead to recalls or safety alerts, reputational harm, adverse verdicts or costly settlements, and could has an adverse effect on the company business, results of operations, financial condition and cash flows.
- Restrictions on import and an increase in shipment cost may adversely impact the company business, cash flows and results of operations.
- The company relies on limited suppliers for its products, loss of these suppliers may has an adverse effect on the company business, results of operations and financial conditions.
- The Company has reported negative cash flows in the recent period. Negative cash flows in the future could adversely affect its results of the company operations and financial condition.
- The company has in the past entered into related party transactions and its may continue to does so in the future.
- The company revenue is significantly concentrated in its top five states, contributing a major portion of its total revenue. Any adverse economic, regulatory, or operational developments in these key regions could materially impact the company business performance, revenue generation, and overall financial results.
- The company has undertaken material acquisitions in the past, and there is no assurance that these acquisitions will yield the intended benefits.
- Any change in Government policies or reduction in tender-based opportunities may affect the company business operations and financial performance.
- The company business has experienced employee attrition over the past three financial years and the stub period, which may impact operational continuity and increase recruitment and training costs. High turnover could also affect the retention of key talent and expertise critical to its growth and performance.
- Under-utilization of the company manufacturing facilities could adversely affect its business operations and financial performance.
- Delay in registration of Products in multiple geographical locations across the world may affect the company revenue generation and overall financial performance.
- The company products has Shelf-Life, any inability on its part to deliver the company products at the right time in the markets could has a material adverse effect on its business and financial condition.
- The Objects of the Issue for which funds are being raised, are based on the company management estimates and any bank or financial institution or any independent agency has not appraised the same. The deployment of funds in the project is entirely at its discretion, based on the parameters as mentioned in the chapter titles "Objects of the Issue".
- The company does not own the premises of its Registered, Industrial Premises and Godowns.
- Certain of the company Promoter group are in businesses similar to its and has interests in certain companies, which are in similar businesses to the company, and this may result in potential conflict of interest with its.
- The Company has availed unsecured loans which is repayable on demand. Any demand from lenders for repayment of such unsecured loans may adversely affect its cash flows.
- Product liability claims and product recalls could harm the company reputation, business, financial condition, cash flows and results of operations.
- The company has certain outstanding litigation involving its company, promoters, directors. Any adverse outcome of which may adversely affect the company business, reputation and results of operations.
- The company faces foreign exchange risk, which may negatively affect its business, financial condition and results of operations.
- The company is subject to stringent domestic and foreign regulations, and any failures to obtain, renew, or maintain requisite approvals, or any adverse regulatory action, may materially and adversely affect its business, results of operations, and financial condition.
- The company revenue is dependent on the maintenance of existing product lines and service relationships, as well as the market acceptance of new products, services, and innovations.
- The company success depends on stable and reliable logistics and transportation infrastructure. Disruption of logistics and transportation services could impair the ability of its suppliers to deliver raw materials or the company ability to deliver products to its customers and/ or increase the company transportation costs, which may adversely affect its operations.
- None of the company Directors has any prior experience of being a director in any other listed company in India.
- The issuer company does not has any comparable Indian listed peers & the peers which has been disclosed in the red herring prospectus may has a different business model as compared to the company.
- While the company has not received product-related complaints, past machinery breakdowns highlight the need for continuous operational improvements.
- There are certain instances of delays in payment of statutory dues by the company. Any further delays in payment of statutory dues may attract financial penalties from the respective government authorities and in turn may has a material adverse impact on its financial condition and cash flows.
- Certain delays and discrepancies has been detected in its statutory records, as well as in records related to the submission of returns and statutory expenses to the concerned Registrar of Companies.
- The company expansion plan relating to installation of additional plant and machinery and construction of building is subject to the risk of unanticipated delays in implementation and cost overruns.
- The products that the company commercialize may not perform as expected which could adversely affect its business, financial condition and results of operations.
- Any variation in the utilization of the Net Proceeds as disclosed in this Red Herring Prospectus shall be subject to certain compliance requirements, including prior approval of the shareholders of the Company.
- Significant challenges or delays in the Company's innovation and development of new products, technologies, and indications could adversely impact its long-term success.
- The company international operations expose its to complex management, legal, tax and economic risks, which could adversely affect the company business, financial condition and results of operations. Further, its is required to comply with the applicable regulations of the markets where the company export its products as well as obtain registrations to enable export of the company products to other jurisdictions.
- The company inability to maintain an optimal level of Stock for its business may impact the company operations adversely.
- Non-compliance with and changes in, safety, health, environmental and labour laws and other applicable regulations, may adversely affect the company business, results of operations, cash flows and financial condition.
- Its relies on professional staff to be appointed by the company for the Research and Development Activities.
- The company is required to obtain, renew or maintain certain statutory and regulatory permits and approvals required to operates the company business and if its fail to does so in a timely manner or at all and the company business, financial conditions, results of operations, and cash flows may be adversely affected.
- The company operations is concentrated in a geographic area, primarily in Uttar Pradesh, Delhi and Haryana. As a result, any localized social unrest, natural disasters, or similar events could has a significant adverse impact on its business and financial performance.
- The company also sell its products through network of distributors and dealers and any inability to expand or effectively manage its growing distribution and sales network may has an adverse effect on the company business, results of operations and financial condition.
- Brand recognition is important to the success of the company business, and its inability to build and maintain the company brand names will harm its business, financial condition, and results of operation.
- After conversion of Company into public limited the company is required to update the name of its company in some of the statutory approvals, certificates, licenses and registrations dues to the change of Status of the Company.
- The company also engage contract labour for carrying out certain functions of the business operations.
- If the Company is unable to protect its intellectual property, or if the Company infringes on the intellectual property rights of others, its business may be adversely affected.
- The company does not has long term contracts or exclusive arrangements with any of its suppliers, and a significant increase in the cost of, or a shortfall in the availability, or deterioration in the quality, of such input materials could has an adverse effect on the company business and results of operations.
- The company Promoters play key role in its functioning and the company heavily relies on their knowledge and experience in operating its business and therefore, it is critical for the company business that its promoters remain associated with the company.
- The company success depends significantly on its Promoters, and Key Management Personnel. The loss of their services may has a material adverse effect on its business, financial condition and results of operations.
- The company faces competition from organized and unorganized competitors and its inability to compete effectively may has a material adverse impact on the company business, financial condition and results of operations.
- The company faces competition and may not be able to keep pace with the rapid technological changes in the industry.
- The company has been recently converted into public limited company and any non-compliance with the provisions of Companies Act, 2013 may attract penalties against its Company which could impact the company financial and operational performance and reputation.
- The company insurance coverage may not adequately protect its against all losses or the insurance cover may not be available for all the losses depending on the insurance policy, which could adversely affect business, results of operations and financial condition.
- Any failures to comply with financial and other restrictive covenants imposed on its under the company financing agreements may affect its operational flexibility, business, results of operations and prospects.
- The company ability to maintain its competitive position and to implement the company business strategy is dependent to significant extent on its senior management team and other key personnel, in particular, the company Promoters.
- The company Promoters and Directors has interest in its Company, other than reimbursement of expenses incurred or remuneration.
- The company Promoters and members of the Promoter Group has significant control over the Company and has the ability to direct its business and affairs; their interests may conflict with your interests as a shareholder.
- The average cost of acquisition of Equity Shares held by the company Promoters may be less than the Issue Price.
- The company has not made any alternate arrangements for meeting its capital requirements for the Objects of the issue. Further the company has not identified any alternate source of financing the `Objects of the Issue'. Any shortfall in raising / meeting the same could adversely affect its growth plans, operations and financial performance.
- Misconduct by the company employees or failures of its internal processes could harm the company by impairing its ability to attract and retain customers.
- The company failures to manage growth effectively may adversely impact its business, results of operations and financial condition.
- The company is dependent on third parties for the supply of utilities, such as water and electricity, at its manufacturing facilities and any disruption in the supply of such utilities could adversely affect the company operations.
- Improper handling of the company products, or spoilage of and damage to its products, could damage the company reputation and has an adverse effect on its business, results of operations and financial condition.
- The Company has not entered any long-term contracts with any of its customers and the company typically operates based on Contracts/ orders. Inability to maintain regular order flow would adversely impact its revenues and profitability.
- The Company's failures to maintain the quality standards of the Service could adversely impact its business, results of operations and financial condition.
- The company is exposed to the risk of delays or non-payment by its clients and other counter parties, which may also result in cash flow mismatches.
- The company ability to grow its business depends on the company relationships with its customers and any adverse changes in these relationships, or the company inability to enter new relationships and thereby expand its customer network, could negatively affect the company business and results of operations.
- The company may not be successful in implementing its business strategies.
- The company future funds requirements, in the form of issue of capital or securities and/or loans taken by its, may be prejudicial to the interest of the shareholders depending upon the terms on which they are eventually raised.
- There is no monitoring agency appointed by the Company and the deployment of funds are at the discretion of its Management and the company Board of Directors, though it shall be monitored by its Audit Committee.
- If the company is unable to source business opportunities effectively, its may not achieve the company financial objectives.
- The company ability to pay dividends in the future will depends upon its future earnings, financial condition, cash flows, working capital requirements, capital expenditure and restrictive covenants in the company financing arrangements.
- Industry information included in this Red Herring Prospectus has not been derived from any industry report, the industry related information has been used from third party reports and websites. There can be no assurance that such third-party statistical, financial, and other industry information is either complete or accurate.
- The Equity Shares has never been publicly traded, and, after the Issue, the Equity Shares may experience price and volume fluctuations, and an active trading market for the Equity Shares may not develop. Further, the price of the Equity Shares may be volatile, and you may be unable to resell the Equity Shares at or above the Issue Price, or at all.
- The sale of Equity Shares by the company Promoters or other significant shareholder(s) may adversely affect the trading price of the Equity Shares.
- There is restrictions on daily movements in the price of the Equity Shares, which may adversely affect a shareholder's ability to sell, or the price at which it can sell, Equity Shares at a particular point in time.
- The company may need additional capital and its may not be able to obtain it, which could adversely affect the company liquidity and financial position.
- Failures to maintain confidential information of the company customers could adversely affect its results of operations or damage the company reputation.
- If the company is unable to establish and maintain an effective system of internal controls and compliances, its business and reputation could be adversely affected.
How to check the allotment status of Avience Biomedicals Ltd IPO?
Follow the steps
Open link to the registrar using this URL (https://evault.kfintech.com/ipostatus/).
Select company from dropdown menu.
Enter details- PAN, Application number or DP client ID
Get your allotment status
Open link to the registrar using this URL (https://evault.kfintech.com/ipostatus/).
IPO reads
Stay updated with the latest IPO developments
February 27, 2025 | 5 min read
₹50.11 Cr Balaji Phosphates IPO Opens Feb 28. Issue Details and SWOT AnalysisRead More
February 25, 2025 | 5 min read
Tata Capital Board Approves ₹15,000 Cr Plus Mega IPO; Tata Investment Shares Soar 8%Read More
February 18, 2025 | 5 min read
Busy Week Ahead: 2 SME IPOs and 9 Market Listings – Get the Complete Details HereRead More
October 25, 2024 | 5 min read
Waaree Energies IPO: GMP Soars 106% Amid 76.34x Subscription – Check Your Allotment Status!Read More
October 22, 2024 | 5 min read
Upcoming IPOs: 9 Public Issues Set to Raise ₹10,984.8 Cr – Key Insights Inside!Read More
October 17, 2024 | 5 min read
Hyundai IPO Hits a Speed Bump With 42% Subscription On Day 2 : 4 Reasons WhyRead More
September 6, 2024 | 5 min read
Bajaj Housing Finance IPO: All You Need to KnowRead MoreOctober 17, 2024 | 5 min read
Hyundai IPO Hits a Speed Bump With 42% Subscription On Day 2 : 4 Reasons WhyRead More
August 26, 2024 | 5 min read
Premier Energies IPO: Key Details Ahead of the ₹2,830.40 Cr Issue LaunchRead MoreMore on IPOs
Navigate your way to other IPO resources
Latest videos on IPOs
IPO highlights & details!
FAQs on IPO
Get answers to all your questions here!
The IPO opens on 18 Jun 2026 & closes on 22 Jun 2026.
Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi. Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of Incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi.
Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India. In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections.
The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.
The Company has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs. Being purely into B2B and B2G market, products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing, the Company also act as distributors and traders of medical equipments. A new production facility was established in Noida in 2021 thereby starting its e-commerce operations.
The Company is planning a fresh issue of 17,28,000 equity shares of face value of Rs 10/- each.
Avience Biomedicals Ltd IPO will close on 22 Jun 2026.
- Experienced Management Team and trained Employees.
- Optimal Utilization of Resources.
- Quality assurance and control.
- Cordial relationships with our clients.
| S.No | Promoters Name | Pre Issue Shares | Pre Issue Percentage | Post Issue Shares | Post Issue Percentage |
|---|---|---|---|---|---|
| 1 | Dharam Deo Choudhary | 2038756 | 50.57 | 2038756 | 37.17 |
| 2 | Ram Nagina Choudhary | 642370 | 15.93 | 642370 | 11.71 |
| 3 | Janardan Pal | 420359 | 10.43 | 420359 | 7.66 |
| 4 | Deepa Choudhary | 438400 | 10.88 | 438400 | 7.99 |
| 5 | Kapil Deo Choudhary | 1000 | 0.02 | 1000 | 0.02 |
| 6 | Geeta Choudhary | 1000 | 0.02 | 1000 | 0.02 |
| 7 | Arti Pal | 1000 | 0.02 | 1000 | 0.02 |
- The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose its to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.
- The company is dependent on certain customers for a portion of its revenues. The loss of any of its major customers dues to any adverse development or significant reduction in business from its major customers may adversely affect the company business, financial condition, results of operations and future prospects.
- The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also faces risks in sourcing raw materials and components from third parties for the manufacturing and assembly of its medical equipment. Any disruption in the supply of these goods or materials could adversely impact the company business, operations, and financial condition.
- The company Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors of its Company as required under the provisions of ICDR.
- The company business derives a significant portion of its revenue from the trading sector, and any potential instability in this area could pose a risk to the company overall performance.
- The purchase and sale of medical devices and equipment for the company trading activities is significantly dependent on related parties.
- Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negatively impact the company business, financial condition, and operational results.
- The company requires sizeable amounts of working capital for its continued operation and growth. The company inability to meet its working capital requirements could has a material adverse effect on the company business, results of operations and financial condition.
- The company business depends on the efficient functioning of its manufacturing facilities and assembly units. Although the company has not received any product-related complaints, occasional machinery breakdowns in the past highlight the importance of regular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair could has an adverse impact on the company operations, cash flows, financial condition, and results.
- The company import a portion of its raw material supply from China. Restrictions on or import duties relating to materials and equipment imported for the company manufacturing operations as well as restrictions on or import duties levied on its products in the company export markets may adversely affect its business prospects, financial performance and cash flows.
- Quality problems and product liability claims could lead to recalls or safety alerts, reputational harm, adverse verdicts or costly settlements, and could has an adverse effect on the company business, results of operations, financial condition and cash flows.
- Restrictions on import and an increase in shipment cost may adversely impact the company business, cash flows and results of operations.
- The company relies on limited suppliers for its products, loss of these suppliers may has an adverse effect on the company business, results of operations and financial conditions.
- The Company has reported negative cash flows in the recent period. Negative cash flows in the future could adversely affect its results of the company operations and financial condition.
- The company has in the past entered into related party transactions and its may continue to does so in the future.
- The company revenue is significantly concentrated in its top five states, contributing a major portion of its total revenue. Any adverse economic, regulatory, or operational developments in these key regions could materially impact the company business performance, revenue generation, and overall financial results.
- The company has undertaken material acquisitions in the past, and there is no assurance that these acquisitions will yield the intended benefits.
- Any change in Government policies or reduction in tender-based opportunities may affect the company business operations and financial performance.
- The company business has experienced employee attrition over the past three financial years and the stub period, which may impact operational continuity and increase recruitment and training costs. High turnover could also affect the retention of key talent and expertise critical to its growth and performance.
- Under-utilization of the company manufacturing facilities could adversely affect its business operations and financial performance.
- Delay in registration of Products in multiple geographical locations across the world may affect the company revenue generation and overall financial performance.
- The company products has Shelf-Life, any inability on its part to deliver the company products at the right time in the markets could has a material adverse effect on its business and financial condition.
- The Objects of the Issue for which funds are being raised, are based on the company management estimates and any bank or financial institution or any independent agency has not appraised the same. The deployment of funds in the project is entirely at its discretion, based on the parameters as mentioned in the chapter titles "Objects of the Issue".
- The company does not own the premises of its Registered, Industrial Premises and Godowns.
- Certain of the company Promoter group are in businesses similar to its and has interests in certain companies, which are in similar businesses to the company, and this may result in potential conflict of interest with its.
- The Company has availed unsecured loans which is repayable on demand. Any demand from lenders for repayment of such unsecured loans may adversely affect its cash flows.
- Product liability claims and product recalls could harm the company reputation, business, financial condition, cash flows and results of operations.
- The company has certain outstanding litigation involving its company, promoters, directors. Any adverse outcome of which may adversely affect the company business, reputation and results of operations.
- The company faces foreign exchange risk, which may negatively affect its business, financial condition and results of operations.
- The company is subject to stringent domestic and foreign regulations, and any failures to obtain, renew, or maintain requisite approvals, or any adverse regulatory action, may materially and adversely affect its business, results of operations, and financial condition.
- The company revenue is dependent on the maintenance of existing product lines and service relationships, as well as the market acceptance of new products, services, and innovations.
- The company success depends on stable and reliable logistics and transportation infrastructure. Disruption of logistics and transportation services could impair the ability of its suppliers to deliver raw materials or the company ability to deliver products to its customers and/ or increase the company transportation costs, which may adversely affect its operations.
- None of the company Directors has any prior experience of being a director in any other listed company in India.
- The issuer company does not has any comparable Indian listed peers & the peers which has been disclosed in the red herring prospectus may has a different business model as compared to the company.
- While the company has not received product-related complaints, past machinery breakdowns highlight the need for continuous operational improvements.
- There are certain instances of delays in payment of statutory dues by the company. Any further delays in payment of statutory dues may attract financial penalties from the respective government authorities and in turn may has a material adverse impact on its financial condition and cash flows.
- Certain delays and discrepancies has been detected in its statutory records, as well as in records related to the submission of returns and statutory expenses to the concerned Registrar of Companies.
- The company expansion plan relating to installation of additional plant and machinery and construction of building is subject to the risk of unanticipated delays in implementation and cost overruns.
- The products that the company commercialize may not perform as expected which could adversely affect its business, financial condition and results of operations.
- Any variation in the utilization of the Net Proceeds as disclosed in this Red Herring Prospectus shall be subject to certain compliance requirements, including prior approval of the shareholders of the Company.
- Significant challenges or delays in the Company's innovation and development of new products, technologies, and indications could adversely impact its long-term success.
- The company international operations expose its to complex management, legal, tax and economic risks, which could adversely affect the company business, financial condition and results of operations. Further, its is required to comply with the applicable regulations of the markets where the company export its products as well as obtain registrations to enable export of the company products to other jurisdictions.
- The company inability to maintain an optimal level of Stock for its business may impact the company operations adversely.
- Non-compliance with and changes in, safety, health, environmental and labour laws and other applicable regulations, may adversely affect the company business, results of operations, cash flows and financial condition.
- Its relies on professional staff to be appointed by the company for the Research and Development Activities.
- The company is required to obtain, renew or maintain certain statutory and regulatory permits and approvals required to operates the company business and if its fail to does so in a timely manner or at all and the company business, financial conditions, results of operations, and cash flows may be adversely affected.
- The company operations is concentrated in a geographic area, primarily in Uttar Pradesh, Delhi and Haryana. As a result, any localized social unrest, natural disasters, or similar events could has a significant adverse impact on its business and financial performance.
- The company also sell its products through network of distributors and dealers and any inability to expand or effectively manage its growing distribution and sales network may has an adverse effect on the company business, results of operations and financial condition.
- Brand recognition is important to the success of the company business, and its inability to build and maintain the company brand names will harm its business, financial condition, and results of operation.
- After conversion of Company into public limited the company is required to update the name of its company in some of the statutory approvals, certificates, licenses and registrations dues to the change of Status of the Company.
- The company also engage contract labour for carrying out certain functions of the business operations.
- If the Company is unable to protect its intellectual property, or if the Company infringes on the intellectual property rights of others, its business may be adversely affected.
- The company does not has long term contracts or exclusive arrangements with any of its suppliers, and a significant increase in the cost of, or a shortfall in the availability, or deterioration in the quality, of such input materials could has an adverse effect on the company business and results of operations.
- The company Promoters play key role in its functioning and the company heavily relies on their knowledge and experience in operating its business and therefore, it is critical for the company business that its promoters remain associated with the company.
- The company success depends significantly on its Promoters, and Key Management Personnel. The loss of their services may has a material adverse effect on its business, financial condition and results of operations.
- The company faces competition from organized and unorganized competitors and its inability to compete effectively may has a material adverse impact on the company business, financial condition and results of operations.
- The company faces competition and may not be able to keep pace with the rapid technological changes in the industry.
- The company has been recently converted into public limited company and any non-compliance with the provisions of Companies Act, 2013 may attract penalties against its Company which could impact the company financial and operational performance and reputation.
- The company insurance coverage may not adequately protect its against all losses or the insurance cover may not be available for all the losses depending on the insurance policy, which could adversely affect business, results of operations and financial condition.
- Any failures to comply with financial and other restrictive covenants imposed on its under the company financing agreements may affect its operational flexibility, business, results of operations and prospects.
- The company ability to maintain its competitive position and to implement the company business strategy is dependent to significant extent on its senior management team and other key personnel, in particular, the company Promoters.
- The company Promoters and Directors has interest in its Company, other than reimbursement of expenses incurred or remuneration.
- The company Promoters and members of the Promoter Group has significant control over the Company and has the ability to direct its business and affairs; their interests may conflict with your interests as a shareholder.
- The average cost of acquisition of Equity Shares held by the company Promoters may be less than the Issue Price.
- The company has not made any alternate arrangements for meeting its capital requirements for the Objects of the issue. Further the company has not identified any alternate source of financing the `Objects of the Issue'. Any shortfall in raising / meeting the same could adversely affect its growth plans, operations and financial performance.
- Misconduct by the company employees or failures of its internal processes could harm the company by impairing its ability to attract and retain customers.
- The company failures to manage growth effectively may adversely impact its business, results of operations and financial condition.
- The company is dependent on third parties for the supply of utilities, such as water and electricity, at its manufacturing facilities and any disruption in the supply of such utilities could adversely affect the company operations.
- Improper handling of the company products, or spoilage of and damage to its products, could damage the company reputation and has an adverse effect on its business, results of operations and financial condition.
- The Company has not entered any long-term contracts with any of its customers and the company typically operates based on Contracts/ orders. Inability to maintain regular order flow would adversely impact its revenues and profitability.
- The Company's failures to maintain the quality standards of the Service could adversely impact its business, results of operations and financial condition.
- The company is exposed to the risk of delays or non-payment by its clients and other counter parties, which may also result in cash flow mismatches.
- The company ability to grow its business depends on the company relationships with its customers and any adverse changes in these relationships, or the company inability to enter new relationships and thereby expand its customer network, could negatively affect the company business and results of operations.
- The company may not be successful in implementing its business strategies.
- The company future funds requirements, in the form of issue of capital or securities and/or loans taken by its, may be prejudicial to the interest of the shareholders depending upon the terms on which they are eventually raised.
- There is no monitoring agency appointed by the Company and the deployment of funds are at the discretion of its Management and the company Board of Directors, though it shall be monitored by its Audit Committee.
- If the company is unable to source business opportunities effectively, its may not achieve the company financial objectives.
- The company ability to pay dividends in the future will depends upon its future earnings, financial condition, cash flows, working capital requirements, capital expenditure and restrictive covenants in the company financing arrangements.
- Industry information included in this Red Herring Prospectus has not been derived from any industry report, the industry related information has been used from third party reports and websites. There can be no assurance that such third-party statistical, financial, and other industry information is either complete or accurate.
- The Equity Shares has never been publicly traded, and, after the Issue, the Equity Shares may experience price and volume fluctuations, and an active trading market for the Equity Shares may not develop. Further, the price of the Equity Shares may be volatile, and you may be unable to resell the Equity Shares at or above the Issue Price, or at all.
- The sale of Equity Shares by the company Promoters or other significant shareholder(s) may adversely affect the trading price of the Equity Shares.
- There is restrictions on daily movements in the price of the Equity Shares, which may adversely affect a shareholder's ability to sell, or the price at which it can sell, Equity Shares at a particular point in time.
- The company may need additional capital and its may not be able to obtain it, which could adversely affect the company liquidity and financial position.
- Failures to maintain confidential information of the company customers could adversely affect its results of operations or damage the company reputation.
- If the company is unable to establish and maintain an effective system of internal controls and compliances, its business and reputation could be adversely affected.
The Issue type of Avience Biomedicals Ltd is Book Building - SME.
The minimum application for shares of Avience Biomedicals Ltd is 1200.
The total shares issue of Avience Biomedicals Ltd is 1453800.
Initial public issue of up to 14,53,800 equity shares of face value of Rs. 10/- each ("The Equity Shares") of Avience Biomedicals Limited ("The Company" or "ABL" or The "Issuer") at an issue price of Rs. 196-208 per equity share for cash, aggregating up to Rs. 28.49-30.24 Crores ("Public Issue") out of which 82,200 equity shares of face value of Rs. 10 each, at an issue price of Rs. 196-208 per equity share for cash, aggregating Rs. 1.61-1.71 Crores will be reserved for subscription by the market maker to the issue (The "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 13,71,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. 196-208 per equity share for cash, aggregating upto Rs. 26.88-28.53 Crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.50% and 25.01% respectively of the post-issue paid-up equity share capital of the company.
Price Band: Rs. 196/- to Rs. 208/- per equity share of face value Rs. 10/- each.
The floor price is 19.6 times the face value and cap price is 20.8 times the face value of the equity.
Bids can be made for a minimum of 600 equity shares and in multiples of 600 equity shares thereafter.